Article Title：Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles Author：Bin Li Journal Title：Nature Nanotechnology Impact Factor：38.3

Article Title：Mammalian IRE1α dynamically and functionally coalesces with stress granules Author：Songzi Liu Journal Title：Nature cell biology Impact Factor：21.3

n 2022, the U.S. Food and Drug Administration (FDA) granted its first approval for the use of organoid and organ-on-a-chip technologies in new drug development research, marking a milestone in the field of biomedical research.

Article Title：Bacteria-Anchoring Hybrid Liposome Capable of Absorbing Multiple Toxins for Antivirulence Therapy of Escherichia coli Infection. Author：Lixian Jiang Journal Title：ACS Nano Impact Factor：30.083

In June 2024, the pen injector independently developed and produced by Wuxi NEST Biotechnology Co., Ltd. (hereinafter referred to as NEST) won the US Food and Drug Administration (FDA) 510 (k) Letter!